Novartis Ag (NVS) Current Taxes (2009 - 2025)

Novartis Ag (NVS) has 11 years of Current Taxes data on file, last reported at $2.0 billion in Q4 2025.

• Quarterly Current Taxes rose 23.14% year-over-year to $2.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 billion (up 23.14% YoY) and the FY2025 annual result came in at $2.0 billion, up 23.14% from the prior year.
• Current Taxes retreated to $2.0 billion in Q4 2025 per NVS's latest filing, from $2.8 billion in the prior quarter.
• The five-year high for Current Taxes was $2.8 billion in Q2 2025, with the low at -$301.0 million in Q1 2024.
• Average Current Taxes over 5 years is $1.9 billion, with a median of $2.2 billion recorded in 2021.
• Year-over-year, Current Taxes dropped 27.61% in 2024 and surged 47.26% in 2025.
• Novartis Ag's Current Taxes stood at $2.4 billion in 2021, then gained by 4.89% to $2.5 billion in 2022, then fell by 25.27% to $1.9 billion in 2023, then retreated by 15.53% to $1.6 billion in 2024, then climbed by 23.14% to $2.0 billion in 2025.
• Business Quant data shows NVS's Current Taxes at $2.0 billion in Q4 2025, $2.8 billion in Q2 2025, and $1.6 billion in Q4 2024.